Institutional Ownership
Beam Therapeutics Inc
CUSIP 07373V105COMBEAMQ1 2026
13D / 13G Filings
55
Schedule 13D/13G on record
Beneficial Filers
13
Distinct reporting persons
Largest Stake
15.0%
Max % of class reported
Institutional Holders
243
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
55 filings · latest Feb 9, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 9, 2026 | State Street Corporation | 13G | 5.2% | 5.23M | SEC |
| 2 | Feb 5, 2026 | Farallon Capital Partners, L.P. | 13G/A | 10.0% | 10.14M | SEC |
| 3 | Feb 5, 2026 | Fmr LLC | 13G/A | 12.6% | 12.75M | SEC |
| 4 | Feb 3, 2026 | Ark Investment Management LLC | 13G/A | 12.3% | 12.47M | SEC |
| 5 | Nov 5, 2025 | Fmr LLC | 13G/A | 13.6% | 13.77M | SEC |
| 6 | Aug 7, 2025 | Ark Investment Management LLC | 13G/A | 10.3% | 10.41M | SEC |
| 7 | Aug 6, 2025 | Fmr LLC | 13G/A | 15.0% | 15.08M | SEC |
| 8 | May 15, 2025 | Arch Venture Fund Ix, L.P. | 13G/A | 4.6% | 4.60M | SEC |
| 9 | May 13, 2025 | Farallon Capital Partners, L.P. | 13G/A | 10.0% | 9.97M | SEC |
| 10 | Apr 17, 2025 | Blackrock, Inc. | 13G/A | 7.5% | 7.50M | SEC |
45 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Beam Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 12.45M | $296.74M |
| 2 | Ark Investment Management LLC | 12.13M | $289.14M |
| 3 | Farallon Capital Management LLC | 10.13M | $241.51M |
| 4 | Blackrock, Inc. | 8.49M | $202.26M |
| 5 | State Street Corp | 5.70M | $135.81M |
| 6 | Arch Venture Management, LLC | 4.54M | $108.19M |
| 7 | Sumitomo Mitsui Trust Group, Inc. | 3.83M | $91.16M |
| 8 | Amova Asset Management Americas, Inc. | 3.83M | $91.16M |
| 9 | Kynam Capital Management, LP | 3.68M | $87.75M |
| 10 | Geode Capital Management, LLC | 2.42M | $57.65M |